Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Doxycycline Plus Ivermectin Versus Ivermectin Alone for Treatment of Patients With Onchocerciasis." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431508/all/Doxycycline_plus_ivermectin_versus_ivermectin_alone_for_treatment_of_patients_with_onchocerciasis.
Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431508/all/Doxycycline_plus_ivermectin_versus_ivermectin_alone_for_treatment_of_patients_with_onchocerciasis. Accessed January 15, 2026.
Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431508/all/Doxycycline_plus_ivermectin_versus_ivermectin_alone_for_treatment_of_patients_with_onchocerciasis
Doxycycline Plus Ivermectin Versus Ivermectin Alone for Treatment of Patients With Onchocerciasis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431508/all/Doxycycline_plus_ivermectin_versus_ivermectin_alone_for_treatment_of_patients_with_onchocerciasis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis
ID - 431508
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431508/all/Doxycycline_plus_ivermectin_versus_ivermectin_alone_for_treatment_of_patients_with_onchocerciasis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -

Cochrane Abstracts

